Ceftazidime

Product NDC: 25021-127
11-digit product format: 250210127
Labeler code: 25021
Product ID: 25021-127_6b34b5ad-001f-4c39-8415-a223eb692b46
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ceftazidime
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: Sagent Pharmaceuticals
Application: ANDA062640
Marketing category: ANDA
Marketing start: 2008-05-15
Substance: CEFTAZIDIME
Active strength: 1 g/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	25021-127		D	Discontinued by firm		2026-08-03
excluded package	package	25021-127	25021-127-66	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	25021-127-66	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	25021-127-66	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	25021-127-66	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	25021-127-66	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	25021-127-66	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	25021-127-66	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	25021-127-66	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	25021-127-66	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	25021-127-66	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	25021-127-66	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	25021-127-66	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	25021-127-66	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A062640-001	CEFTAZIDIME	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20
A062640-002	CEFTAZIDIME	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20
A062640-003	CEFTAZIDIME	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20
A062640-004	CEFTAZIDIME	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A062640-002	AP
A062640-003	AP
A062640-004	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062640-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-004	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-004	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062640-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-004	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-004	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-003	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-004	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-003	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-004	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-003	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-004	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-003	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-004	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-003	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-004	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062640-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-003	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-004	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062640-002	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062640-003	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062640-004	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062640-002	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062640-003	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062640-004	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062640-002	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062640-003	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062640-004	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062640-002	AP	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Ceftazidime
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFTAZIDIME	1 g/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9M416Z9QNR	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1659283	Internal RxNorm lookup
1659287	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
112c5457-8d71-49f5-b531-9761d7d38c93	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5	Product name	1	20150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
25021-127-20	Ceftazidime	1 in 1 VIAL	INJECTION, POWDER, FOR SOLUTION	1		11
25021-127-20	Ceftazidime	25 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	25		11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
25021-127-20	EA - Each	25021-127	21a42dad-cda4-4d28-bd57-33adc07e6c76	1	2012-07-24
25021-127-66	EA - Each	25021-127	44f7f396-7806-414a-8bd4-0e06d8c18e25	1	2015-07-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ceftazidime	ACTIVE INGREDIENT	9M416Z9QNR	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]	6
CEFTAZIDIME ANHYDROUS	ACTIVE MOIETY	DZR1ENT301	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]	6
sodium carbonate	INACTIVE INGREDIENT	45P3261C7T	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]	6
ceftazidime	ACTIVE INGREDIENT	9M416Z9QNR	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]	2
CEFTAZIDIME ANHYDROUS	ACTIVE MOIETY	DZR1ENT301	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]	2
sodium carbonate	INACTIVE INGREDIENT	45P3261C7T	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
25021-127	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]	11	Current NDC, Legacy NDC, 2 package rows	20201007_112c5457-8d71-49f5-b531-9761d7d38c93.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ceftazidime	CEFTAZIDIME	WG Critical Care, LLC	22d6534c-4488-48a1-8d78-e2fb908259de	2026-06-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062640 application number: ANDA062640
Ceftazidime	CEFTAZIDIME	Sagent Pharmaceuticals	aec64360-8452-4987-a366-a5a4f8762ab6	2024-01-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062640 application number: ANDA062640
Ceftazidime	CEFTAZIDIME	WG Critical Care, LLC	bcc81df2-20e3-4738-bfcf-301da883c1d9	2023-09-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062640 application number: ANDA062640
Ceftazidime	CEFTAZIDIME	Sagent Pharmaceuticals	112c5457-8d71-49f5-b531-9761d7d38c93	2020-10-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062640 application number: ANDA062640 ndc (product): 25021-127

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9M416Z9QNR	CEFTAZIDIME	78439-06-2	CEFTAZIDIME

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1659283	cefTAZidime 1 GM Injection	PSN	112c5457-8d71-49f5-b531-9761d7d38c93	11
1659287	cefTAZidime 2 GM Injection	PSN	112c5457-8d71-49f5-b531-9761d7d38c93	11
1659283	ceftazidime 1000 MG Injection	SCD	112c5457-8d71-49f5-b531-9761d7d38c93	11
1659287	ceftazidime 2000 MG Injection	SCD	112c5457-8d71-49f5-b531-9761d7d38c93	11
1659283	ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection	SY	112c5457-8d71-49f5-b531-9761d7d38c93	11
1659287	ceftazidime (as ceftazidime pentahydrate) 2000 MG Injection	SY	112c5457-8d71-49f5-b531-9761d7d38c93	11
1659283	ceftazidime 1 GM Injection	SY	112c5457-8d71-49f5-b531-9761d7d38c93	11
1659287	ceftazidime 2 GM Injection	SY	112c5457-8d71-49f5-b531-9761d7d38c93	11

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
25021-127-20	25021012720	25 VIAL in 1 CARTON (25021-127-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL	25 vial	2008-05-15	0000-00-00	No	No	Current
25021-127-66	25021012766	25 VIAL in 1 CARTON (25021-127-66) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL	25 vial	2015-07-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Ceftazidime for Injection, USP	Sagent Pharmaceuticals	2022-12-07	HUMAN PRESCRIPTION DRUG LABEL	8
Ceftazidime for Injection, USP	Sagent Pharmaceuticals	2020-10-05	HUMAN PRESCRIPTION DRUG LABEL	11